BH
Benjamin A Horowitz
10% Owner

Benjamin A Horowitz insider trades: Braveheart Bio (BRVE) stock buys and sales

10% Owner, Braveheart Bio Last trade Aug 7, 2026 104 Form 4 filings
$11.8M
Sold, last 12 months
2 sales
$50.1M
Bought, last 12 months
4 buys
73
Open-market trades
since 2005
19
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Benjamin reports to the SEC

and 13 more companies

Open-market buys and sales

73 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 7, 2026BRVE↑ Buy$19.8M
Jul 27, 2026SCTX↑ Buy$5.0M
Jun 2, 2026NAUT↓ Sell$10.8M
Jun 2, 2026NAUT↓ Sell$902K
Jan 6, 2026NAVN↑ Buy$15.9M
Dec 19, 2025NAVN↑ Buy$9.4M
Sep 9, 2025IOT↓ Sell$19.4M
Sep 9, 2025IOT↓ Sell$9.9M
Sep 9, 2025IOT↓ Sell$1.3M
Jun 10, 2025IOT↓ Sell$8.8M
Jun 10, 2025IOT↓ Sell$3.5M
Jun 10, 2025IOT↓ Sell$2.7M
Jun 10, 2025IOT↓ Sell$1.5M
Mar 10, 2025IOT↓ Sell$7.5M
Mar 10, 2025IOT↓ Sell$2.5M
Dec 10, 2024IOT↓ Sell$3.5M
Dec 10, 2024IOT↓ Sell$1.7M
Oct 15, 2024CAMP↑ Buy$6.0M
Oct 15, 2024CAMP↑ Buy$2.0M
Sep 11, 2024IOT↓ Sell$9.5M
Sep 11, 2024IOT↓ Sell$4.0M
Sep 11, 2024IOT↓ Sell$1.4M
Jun 13, 2024IOT↓ Sell$8.0M
Dec 14, 2023IOT↓ Sell$9.6M
Sep 8, 2023IOT↓ Sell$9.6M
Sep 8, 2023IOT↓ Sell$2.5M
Jun 8, 2023IOT↓ Sell$9.2M
Jun 8, 2023IOT↓ Sell$1.0M
Mar 8, 2023IOT↓ Sell$7.5M
Sep 7, 2022IOT↓ Sell$3K
Dec 17, 2021IOT↑ Buy$91.9M
Aug 9, 2021DOCN↓ Sell$10.4M
Aug 9, 2021DOCN↓ Sell$562K
Aug 3, 2021OKTA↓ Sell$19.7M
Jul 7, 2021OKTA↓ Sell$39.7M
May 24, 2021COIN↓ Sell$4.0M
Apr 15, 2021COIN↓ Sell$6.2M
Apr 15, 2021COIN↓ Sell$128K
Apr 14, 2021COIN↓ Sell$82.8M
Apr 14, 2021COIN↓ Sell$17.6M
Apr 14, 2021COIN↓ Sell$6.9M
Apr 14, 2021COIN↓ Sell$3.3M
Apr 14, 2021COIN↓ Sell$1.6M
Oct 14, 2020OKTA↓ Sell$12.2M
Oct 13, 2020OKTA↓ Sell$24.6M
Jul 20, 2020OKTA↓ Sell$7.8M
Jul 7, 2020ACCD↓ Sell$110
Jun 22, 2020OKTA↓ Sell$7.5M
May 18, 2020OKTA↓ Sell$6.9M
Apr 27, 2020OKTA↓ Sell$5.9M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other BRVE insiders

Open-market trades in the last 12 months

About Benjamin A Horowitz's insider trades

Benjamin A Horowitz is a 10% owner of Braveheart Bio (BRVE). Since Sep 28, 2005, Benjamin has reported 8 open-market purchases worth $150.0M and 65 sales worth $633.9M on SEC Form 4. In the last 12 months: 4 buys ($50.1M) and 2 sales ($11.8M).

Their filings also include conversions (39 filings), other transactions (28 filings), grants and awards (16 filings), option exercises (10 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BRVE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.